Pfizer pumps $600M into venture capital arm

Several drugmakers, including Pfizer, have cut back on neuroscience research after a string of costly trials yielded disappointing results, with some of them betting on startups that are focusing on such areas.

via FOX BUSINESS NEWS Markets
https://ift.tt/2M33SgQ